drugset / Trial / NCT00528697
A Safety and Efficacy Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to test if the investigational medication ABT-089 is a safe and effective treatment for children with Attention-Deficit/Hyperactivity Disorder or ADHD.
Timeline
- Start
- 2007-09
- Primary completion
- 2008-04
- Completion
- 2008-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atomoxetine | Other / unclassified | 10 mg | — |
| Comparator | Atomoxetine | Other / unclassified | 18 mg | — |
| Comparator | Atomoxetine | Other / unclassified | 25 mg | — |
| Subject | Pozanicline | Small molecule | 0.5 mg | — |
| Subject | Pozanicline | Small molecule | 1 mg | — |
| Subject | Pozanicline | Small molecule | 5 mg | — |
| Subject | Pozanicline | Small molecule | 10 mg | — |